Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Background High incidence of thrombosis in COVID‐19 patients indicates a
hypercoagulable state. Hence, exploring the involvement of antiphospholipid antibodies …

Objectives A novel longitudinal clustering technique was applied to comprehensive
autoantibody data from a large, well-characterised, multinational inception systemic lupus …

Background Around 10% of all thrombotic cerebrovascular events (CVE) occur in young
population and in a large proportion of those the trigger remains undetermined …

Background The antiphospholipid syndrome (APS) is characterized by thrombosis and/or
pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti …

Review of the guideline followed the standard BSH guidelines procedure. Following review
of the draft guideline by the BSH Haemostasis and Thrombosis Task Force and the BSH …

The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular
thrombosis or miscarriages but includes additional manifestations that cannot be explained …

Objective. Most clinicians use the 2006 Sydney classification criteria to evaluate patients
suspected of having antiphospholipid syndrome (APS). Although sensitive and specific for …

Background Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by
the presence of antiphospholipid antibodies (aPLs) and thrombotic events. The association …